iRegene

Wuhan, China · Founded 2017 · Privately Held (backing)

Developer of chemically-derived allogeneic cell therapies aims to provide first-in-class treatments for major degenerative diseases. iRegene is based in Wuhan, China and was founded in 2017. Its last reported valuation was $569 million in Apr 2025. It has raised $393 million.

Last reported valuation

$568.6M

Oct 2026

Priced at

—

Total raised

$392.8M

Last round

—

How much has iRegene raised?

$392.8Macross 0 recorded rounds

Free account

More of iRegene with a free account

·The complete investor list: 14 names
·Watch iRegene: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

iRegene investors

14 investors are on record for iRegene, including Northern Light Venture Capital, Vertex Ventures China, GSR United Capital and Orinno Capital.

For fundraisers

Raising for a company like iRegene?

14 investors have backed iRegene.

See all 14 investors →

Frequently asked about iRegene

How much has iRegene raised?: iRegene has raised $392.8M in total across 0 recorded funding rounds.